NCT02048371 2023-11-07
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes
Sarcoma Alliance for Research through Collaboration
Phase 2 Completed
Sarcoma Alliance for Research through Collaboration
Dana-Farber Cancer Institute
Bayer
Dana-Farber Cancer Institute